BioAge Labs, Inc.
BIOA
$10.18
$0.9610.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.46% | -66.79% | 38.81% | 9.73% | -72.35% |
| Total Depreciation and Amortization | -15.52% | 56.76% | -21.28% | 23.68% | -22.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.20% | 8.59% | 29.55% | 7.02% | 30.75% |
| Change in Net Operating Assets | 168.66% | 76.27% | -155.46% | 117.97% | 258.27% |
| Cash from Operations | 19.66% | -15.01% | -237.93% | 65.59% | 5.39% |
| Capital Expenditure | 86.16% | 62.68% | -1,538.46% | 91.48% | -771.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 183.08% | 80.04% | -- | -- | -- |
| Cash from Investing | 182.10% | 79.94% | -299,853.85% | 91.48% | -771.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -85.76% | 45,914.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 37.77% | -52.71% |
| Cash from Financing | -2.93% | 0.00% | -106.02% | -86.94% | 8,088.40% |
| Foreign Exchange rate Adjustments | 78.26% | -283.33% | -108.76% | 336.21% | -241.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.20% | 61.64% | -587.36% | -88.67% | 1,062.62% |